|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.320 USD | -2.92% |
|
-5.95% | -1.48% |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
Revenues | 42Cr | 59Cr | 160.38Cr | 202.02Cr | 193.3Cr | ||||
Other Revenues, Total | - | 6.54Cr | 3.23Cr | 3.9Cr | 6.06Cr | ||||
Total Revenues | 42Cr | 66Cr | 163.61Cr | 205.92Cr | 199.36Cr | ||||
Cost of Goods Sold, Total | 44Cr | 67Cr | 158.84Cr | 203.38Cr | 185.71Cr | ||||
Gross Profit | -2.74Cr | -1.63Cr | 4.77Cr | 2.54Cr | 14Cr | ||||
Selling General & Admin Expenses, Total | 105.77Cr | 62Cr | 37Cr | 40Cr | 40Cr | ||||
Provision for Bad Debts | - | 9.16Cr | -7L | 1.38Cr | -4L | ||||
R&D Expenses | 12Cr | 7.41Cr | 3.62Cr | 3.77Cr | 1.08Cr | ||||
Other Operating Expenses | -22Cr | -25Cr | -8.2Cr | -7Cr | -4.22Cr | ||||
Other Operating Expenses, Total | 96Cr | 54Cr | 33Cr | 38Cr | 37Cr | ||||
Operating Income | -99Cr | -55Cr | -28Cr | -36Cr | -23Cr | ||||
Interest Expense, Total | -12Cr | -9.6Cr | -4.12Cr | -2.12Cr | -9.21Cr | ||||
Interest And Investment Income | 1.23Cr | 4.51Cr | 36.6L | 1.1Cr | 49.33T | ||||
Net Interest Expenses | -10Cr | -5.08Cr | -3.76Cr | -1.03Cr | -9.2Cr | ||||
Income (Loss) On Equity Invest. | 2.78Cr | 1.57Cr | 3L | -44T | 32.39L | ||||
Currency Exchange Gains (Loss) | -15.52L | -1.59Cr | -93.36L | -24.57L | 4L | ||||
Other Non Operating Income (Expenses) | -3.08Cr | -11Cr | -36.98L | -70.65L | 84.13L | ||||
EBT, Excl. Unusual Items | -109.4Cr | -72Cr | -33Cr | -38Cr | -31Cr | ||||
Gain (Loss) On Sale Of Investments | - | - | 19Cr | 24Cr | -1.18Cr | ||||
Gain (Loss) On Sale Of Assets | 72Cr | - | - | - | - | ||||
Other Unusual Items | -775.83Cr | - | - | -27.78L | 4.7Cr | ||||
EBT, Incl. Unusual Items | -813.62Cr | -72Cr | -14Cr | -14Cr | -27Cr | ||||
Income Tax Expense | 13.04L | 33T | 2L | 4L | 52T | ||||
Earnings From Continuing Operations | -813.75Cr | -72Cr | -14Cr | -14Cr | -27Cr | ||||
Earnings Of Discontinued Operations | -182.07Cr | 30Cr | - | - | - | ||||
Net Income to Company | -995.82Cr | -42Cr | -14Cr | -14Cr | -27Cr | ||||
Minority Interest | 2.15Cr | 9T | - | 12T | -66.37L | ||||
Net Income - (IS) | -993.67Cr | -42Cr | -14Cr | -14Cr | -27Cr | ||||
Preferred Dividend and Other Adjustments | - | - | - | 76Cr | 206.03Cr | ||||
Net Income to Common Incl Extra Items | -993.67Cr | -42Cr | -14Cr | -89Cr | -27Cr | ||||
Net Income to Common Excl. Extra Items | -811.6Cr | -72Cr | -14Cr | -89Cr | -27Cr | ||||
Per Share Items | |||||||||
Net EPS - Basic | -3.36T | -114.81 | -36.77 | -199.2 | -333.55 | ||||
Basic EPS - Continuing Operations | -2.74T | -195.42 | -36.77 | -199.2 | -333.55 | ||||
Basic Weighted Average Shares Outstanding | 29.62L | 36.69L | 38.95L | 44.82L | 19Cr | ||||
Net EPS - Diluted | -3.36T | -114.81 | -622.14 | -199.2 | -333.55 | ||||
Diluted EPS - Continuing Operations | -2.74T | -195.42 | -622.14 | -199.2 | -333.55 | ||||
Diluted Weighted Average Shares Outstanding | 29.62L | 36.69L | 45.15L | 44.82L | 19Cr | ||||
Normalized Basic EPS | -223.61 | -122.13 | -52.83 | -52.54 | -30.67 | ||||
Normalized Diluted EPS | -223.61 | -122.13 | -45.57 | -52.54 | -30.67 | ||||
American Depositary Receipts Ratio (ADR) | 300 | 300 | 300 | 300 | 300 | ||||
Supplemental Items | |||||||||
EBITDA | -90Cr | -51Cr | -26Cr | -34Cr | -22Cr | ||||
EBITA | -99Cr | -55Cr | -28Cr | -36Cr | -23Cr | ||||
EBIT | -99Cr | -55Cr | -28Cr | -36Cr | -23Cr | ||||
EBITDAR | -21Cr | -46Cr | -24Cr | -31Cr | -15Cr | ||||
Total Revenues (As Reported) | - | 66Cr | 163.61Cr | 205.92Cr | 199.36Cr | ||||
Effective Tax Rate - (Ratio) | -0.02 | -0 | -0.17 | -0.27 | -0.02 | ||||
Total Current Taxes | 13.04L | 33T | 2L | 4L | 52T | ||||
Total Deferred Taxes | - | - | - | - | - | ||||
Normalized Net Income | -66Cr | -45Cr | -21Cr | -24Cr | -20Cr | ||||
Supplemental Operating Expense Items | |||||||||
Advertising Expense | - | - | 5.87Cr | 4.69Cr | 1.58Cr | ||||
Marketing Expenses | - | - | - | - | - | ||||
Selling and Marketing Expenses | 76Cr | 34Cr | 22Cr | 24Cr | 24Cr | ||||
General and Administrative Expenses | 30Cr | 28Cr | 15Cr | 16Cr | 16Cr | ||||
Research And Development Expense From Footnotes | 12Cr | 7.41Cr | 3.62Cr | 3.77Cr | 1.08Cr | ||||
Net Rental Expense, Total | 1.43Cr | 4.14Cr | 2.31Cr | 2.93Cr | 2.1Cr | ||||
Imputed Operating Lease Interest Expense | - | 1.44Cr | 48.41L | 49.92L | 98.49L | ||||
Imputed Operating Lease Depreciation | - | 2.7Cr | 1.83Cr | 2.43Cr | 1.57Cr | ||||
Stock-Based Comp., R&D Exp. (Total) | - | - | - | 17.09L | 2L | ||||
Stock-Based Comp., S&M Exp. (Total) | - | - | - | 15.16L | 2L | ||||
Stock-Based Comp., G&A Exp. (Total) | - | - | 2.65Cr | 4.41Cr | 11Cr | ||||
Stock-Based Comp., Other (Total) | -13Cr | -1.91Cr | - | - | - | ||||
Total Stock-Based Compensation | -13Cr | -1.91Cr | 2.65Cr | 4.73Cr | 11Cr |
- Stock Market
- Equities
- UXIN Stock
- Financials Uxin Limited
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















